In vitro activities of telithromycin and 10 oral agents against aerobic and anaerobic pathogens isolated from antral puncture specimens from patients with sinusitis

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 6, 2003, Pages 1963-1967

  Goldstein, Ellie J C ^a,b,c   Citron, Diane M ^a   Merriam, C Vreni ^a   Warren, Yumi ^a   Tyrrel, Kerin L ^a   Fernandez, Helen ^a  

^a R M ALDEN RESEARCH LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFUROXIME; CLARITHROMYCIN; ERYTHROMYCIN; GATIFLOXACIN; KETOLIDE; LEVOFLOXACIN; MOXIFLOXACIN; PENICILLIN G; ROXITHROMYCIN; TELITHROMYCIN;

ADULT; AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; EIKENELLA CORRODENS; FUSOBACTERIUM; HAEMOPHILUS INFLUENZAE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA; NONHUMAN; PEPTOSTREPTOCOCCUS; PREVOTELLA; PRIORITY JOURNAL; SINUSITIS; STREPTOCOCCUS PNEUMONIAE; VEILLONELLA;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIA, AEROBIC; BACTERIA, ANAEROBIC; HUMANS; KETOLIDES; MACROLIDES; MAXILLARY SINUSITIS; MICROBIAL SENSITIVITY TESTS;

EID: 0038440783     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.6.1963-1967.2003     Document Type: Article

References (25)

1. Barman-Balfour, J. A., and D. P. Figgit. 2001. Telithromycin. Drugs 61:815-831.
2. Barry, A. L., P. C. Fuchs, and S. D. Brown. 1998. Antipneumococcal activity of a ketolide (HMR 3647), a streptogramin (quinpristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin). Antimicrob. Agents Chemother. 42:945-946.
3. Brook, I., and A. E. Gober. 1999. Resistance to antimicrobials used for therapy of otitis media and sinusitis: effect of previous antimicrobial therapy and smoking. Ann. Otol. Rhinol. Laryngol. 108:645-647.
4. Canigia, L. F., A. Di Martino, M. Litterio, L. Castello, M. I. Fernandez, R. Rollet, G. Greco, S. Predari, and H. Bianchini. 1999. Comparative in vitro activities of four macrolides at two pH values against gram-negative anaerobic rods other than the Bacteroides fragilis group. Anaerobe 5:451-454.
5. Davies, T. A., B. E. Dewasse, M. R. Jacobs, and P. C. Applebaum. 2000. In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 44:414-417.
6. Doern, G. V., A. Brueggemann, H. P. Holley, Jr., and A. M. Rauch. 1996. Antimicrobial resistance of Streptococcus pneumoniae recovered from out-patients in the United States during winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob. Agents Chemother. 40:1208-1213.
7. Edlund, C., E. Silverstrom, E. Wahlund, and C. E. Nord. 1998. In vitro activity of HMR 3647 against anaerobic bacteria. J. Chemother. 10:280-284.
8. Ednie, L. M., M. R. Jacobs, and P. C. Appelbaum. 1997. Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004). Antimicrob. Agents Chemother. 41:2019-2022.
9. Fuchs, P. C., A. L. Barry, and S. D. Brown. 2001. Influence of variations in test methods on susceptibility of Haemophilus influenzae to ampicillin, azithromycin, clarithromycin, and telithromycin. Antimicrob. Agents Chemother. 39:43-46.
10. Gerardo, S. H., D. M. Citron, M. C. Claros, and E. J. C. Goldstein. 1996. Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides. Antimicrob. Agents Chemother. 40:2413-2415.
11. Goldstein, E. J. C., D. M. Citron, and C. V. Merriam. 1999. Comparative in vitro activity of amoxicillin-clavulanate against aerobic and anaerobic bacteria isolated from antral puncture specimens from patients with sinusitis. Antimicrob. Agents Chemother. 43:705-707.
12. Goldstein, E. J. C., D. M. Citron, C. V. Merriam, Y. Warren, and K. Tyrrell. 1999. Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes. Antimicrob. Agents Chemother. 43:2801-2805.
13. Hoban, D. J., G. C. Zhanel, and J. A. Karlowsky. 1999. In vitro activity of the novel ketolide HMR 3647 and comparative oral antibiotics against Canadian respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Diagn. Microbiol. Infect. Dis. 35:37-44.
14. Hyde, T. B., K. Gay, D. S. Stevens, D. J. Vugia, M. Pass, S. Johnson, N. L. Barrett, W. Schaffner, P. R. Cieslak, P. S. Maupin, E. R. Zell, J. H. Jorgensen, R. R. Facklam, and C. G. Whitney. 2001. Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA 286:1857-1862.
15. Johnson, A. P., C. J. Henwood, L. Tysall, and M. Warner. 2001. Activity of the ketolide telithromycin (HMR-3647) against erythromycin-susceptible and -resistant pneumococci isolated in the UK. Int. J. Antimicrob. Agents 18:73-76.
16. Jones, R. N., and D. J. Biedenbach. 1997. Antimicrobial activity of RU 66647, a new ketolide. Diagn. Microbiol. Infect. Dis. 27:7-12.
17. Jousimies-Somer, H. R., S. Savolainen, and J. S. Ylikoski. 1988. Bacteriological findings of acute maxillary sinusitis in young adults. J. Clin. Microbiol. 26:1919-1925.
18. Low, D. E., J. de Azavedo, K. Weiss, T. Mazzulli, M. Kuhn, D. Church, K. Forward, G. Zhanel, A. Simor, A. McGreer, et al. 2002. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000. Antimicrob. Agents Chemother. 46:1295-1301.
19. Murray, P. R., E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.). 1999. Manual of clinical microbiology, 7th ed. American Society for Microbiology, Washington, D.C.
20. National Committee for Clinical Laboratory Standards. 2001. Methods for antimicrobial susceptibility testing of anaerobic bacteria, 5th ed. Approved standard M11-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
21. National Committee for Clinical Laboratory Standards. 2000. Method for dilution antimicrobial susceptibility testing for bacteria that grow aerobically, 5th ed. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
22. Sinus and Allergy Health Partnership. 2000. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol. Head Neck Surg. 123(Suppl.1):(Part 2):S1-S32.
23. Summanen, P., E. J. Baron, D. M. Citron, C. A. Strong, H. M. Wexler, and S. M. Finegold. 1993. Wadsworth anaerobic bacteriology manual, 5th ed. Star Publishing Co., Belmont, Calif.
24. Thornsberry, C., P. Ogilvie, J. Khan, Y. Mauriz, et al. 1997. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus pneumoniae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. Diagn. Microbiol. Infect. Dis. 29:249-257.
25. U.S. Department of Health and Human Services. 1987. National health survey: prevalence of selected chronic conditions, United States 1983-1985. U.S. Department of Health and Human Services, Hyattsville, Md.